Multiple Sclerosis Banner

Featured Article

Approaches for Better Diagnosis of Pediatric Multiple Sclerosis

Approaches for Better Diagnosis of Pediatric Multiple Sclerosis

Pediatric MS is predominantly inflammatory in nature, with a presentation that is similar to a number of other conditions.

Latest

FDA Warns of Rare Stroke Risk With Multiple Sclerosis Drug

FDA Warns of Rare Stroke Risk With Multiple Sclerosis Drug

A new warning has been added to the multiple sclerosis drug Lemtrada (alemtuzumab) after rare reports of patients suffering strokes and tears in the lining of the arteries in the head and neck.

MS Relapse Drops During Pregnancy but Rises After

MS Relapse Drops During Pregnancy but Rises After

Rates of multiple sclerosis relapse decrease during pregnancy but increase postpartum.

Many Patients Do Not Engage Health Care Provider During MS Relapse

Many Patients Do Not Engage Health Care Provider During MS Relapse

The rate and frequency of relapse vary for patients with multiple sclerosis, and many report not visiting a health care provider during relapse.

FDA: Risk of Severe Increase in Disability Following MS Treatment Discontinuation

FDA: Risk of Severe Increase in Disability Following MS Treatment Discontinuation

From September 2010 to February 2018, the FDA has identified 35 cases of severe increased disability accompanied by the presence of new lesions on MRI that occurred 2 to 24 weeks after stopping treatment with fingolimod.

Ocrevus Labeling Updated With New Info on Timing of Vaccine Administration

Ocrevus Labeling Updated With New Info on Timing of Vaccine Administration

According to a Phase 3b open-label study, Ocrevus may interfere with the effectiveness of non-live vaccines.

Rates of Multiple Sclerosis Relapses Vary Before, During, and After Pregnancy

Rates of Multiple Sclerosis Relapses Vary Before, During, and After Pregnancy

Investigators sought to determine relapse rates of multiple sclerosis decrease prior to pregnancy, during pregnancy, and postpartum.

A New Look at Demyelination and White Matter Density in Multiple Sclerosis

A New Look at Demyelination and White Matter Density in Multiple Sclerosis

Investigators propose that myelocortical multiple sclerosis may be a subtype of multiple sclerosis.

Cannabinoids Mildly Effective for Treating MS Symptoms in Adults

Cannabinoids Mildly Effective for Treating MS Symptoms in Adults

Cannabinoids may be mildly effective at treating spasticity, pain, and bladder dysfunction in adults with multiple sclerosis.

Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis

Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis

Investigators examine the role of physical activity and exercise in the modification of vascular comorbidities and risk factors in individuals with multiple sclerosis.

DMTs Do Not Moderate Disability in Patients With MS and Diabetes, Other Comorbidities

DMTs Do Not Moderate Disability in Patients With MS and Diabetes, Other Comorbidities

All participants were smokers or had either diabetes, cancer, depression, cardiovascular, respiratory, thyroid, or gastrointestinal disease and were receiving a DMT.

Sign Up for Free e-newsletters



CME Focus